CAR-T:

Yifan Huang1, Rong Cao1, Siyang Wang1

  • 1Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.

PubMed
概括

活体CAR-T细胞疗法通过在体内基因修改T细胞,为传统治疗提供了一个有希望的替代方案. 这种方法旨在提高抗瘤有效性和安全性,克服现有疗法的制造挑战.